Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Slozem 300mg Capsules

Discontinued
Active Ingredient:
diltiazem hydrochloride
Company:  
Merck See contact details
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information HCP Med Info
{arrow_left}
{arrow_right}
Change of Marketing Authorisation Holder

Slozem® Marketing Authorisations have been transferred to Zentiva Pharma UK Limited who plan to reintroduce Slozem® in the near future. For further information regarding Slozem® reintroduction, please contact Zentiva directly.
Merck
Company image
Address
Merck Serono Ltd, 5 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, UK
Telephone
+44 (0)208 818 7200
Fax
+44 (0)208 818 7267
Medical Information Direct Line
+44 (0)208 818 7373
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)208 818 7274